Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CENTA ENEMA - HSA Drug Approval Details

Approvals/HSA/CENTA ENEMA

Approved

THERAPEUTIC

CENTA ENEMA

HEALTH CHEMICAL PHARMACEUTICAL CO LTD (TAIWAN)🇸🇬 Health Sciences Authority

Approval Date: Jun 7, 1989
Approval ID: e33f054675217ba4
Company: HEALTH CHEMICAL PHARMACEUTICAL CO LTD (TAIWAN)
Type: Therapeutic

Approval Details

Approval Id: e33f054675217ba4
Drug Name: CENTA ENEMA
Product Name: CENTA ENEMA
Approval Number: SIN03517P
Approval Date: 1989-06-07
Registrant: CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Licence Holder: CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: GENERAL SALE LIST
Dosage Form: ENEMA
Route Of Administration: RECTAL
Atc Code: B05CB01
Atc Item Name: sodium chloride
Pharma Manufacturer Name: CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Active Ingredients

SODIUM CHLORIDE

15%

SODIUM CHLORIDE

15%

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 7, 1989

Approval ID

e33f054675217ba4

Type

Therapeutic

Back to HSA Approvals